![Anthony Milonas, CEO of Alliance Clinical Network. [Photo: LinkedIn]](https://s24806.pcdn.co/wp-content/uploads/2025/11/AllianceClinicalNetwork_AnthonyMilonas-970-1.jpg)
Southlake-based Alliance Clinical Network has named Anthony Milonas as its new chief executive officer. He succeeds founder Anthony Abey, who will remain on the network’s board of directors.
In a statement, Abey said Milonas’ “leadership, integrity, and passion for advancing healthcare make him the perfect fit to lead Alliance into its next phase of growth. I look forward to supporting Anthony and the Alliance organization through my continued involvement on the board.”
Abey served as CEO since January 2018 and guided Alliance Clinical Network through significant growth, establishing “its reputation for operational excellence and patient-centered research,” the company said. He will continue to provide strategic vision and support the organization through his role on the board.
Milonas brings more than two decades of experience leading and scaling multi-site healthcare organizations across North America. According to the company, he previously served as the founding CEO of Ascend Aesthetic Partners and as CEO of Canadian Orthodontic Partners. Previously, he held senior leadership roles at We Care Health Services and CBI Health Group. Throughout his career, Milonas has been “known for building collaborative cultures, implementing data-driven systems, and advancing patient-focused care.”
“I am honored to join Alliance and to work alongside such a talented team,” Milonas said in a statement. “I’m deeply grateful to Anthony Abey for his visionary leadership and the strong foundation he has built, and I look forward to building on the Company’s strong momentum to deepen our impact and advance our shared mission of improving patient lives through clinical research.”
Alliance Clinical Network is a fully integrated, wholly owned and operated group of clinical research sites. The company said that its structure “enables us to maintain consistent quality control, delivering prompt, clean, audit-ready data.” Its database includes over 250,000 consented participants from diverse populations to help “execute complex clinical trials at speed.”
Don’t miss what’s next. Subscribe to Dallas Innovates.
Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.
R E A D N E X T
-
Dallas is aging faster than ever, with seniors facing rising challenges of isolation, health, and care. Technology, when designed with empathy, can bridge these gaps - connecting families, empowering caregivers, and enabling prevention. By building tools with empathy, we can transform elder care from survival to peace of mind and joy.
-
Qualthera, a new company founded by entrepreneur Donald Prentiss, has made its first acquisition—Central Drug in Victoria, Texas—and set its sights on Dallas for its second. Prentiss sees an opportunity in the shifting pharmacy landscape, where changes, including downsizing by large chains, have created service gaps that independent pharmacies could fill.
-
Bowles will advise the Lab’s leadership team and students on fund strategy, investment process, and entrepreneurial execution, and will bring "a practical investor’s perspective" to the lab’s mission of supporting ventures that create measurable social impact.
-
Rather than replace radiologists, UTD researchers say AI could help flag low-risk mammograms for automated review. The approach could cut costs and ease delays as cancer rates rise and the diagnostic workforce shrinks.
-
Take Command’s new COO will sharpen operations as the company builds on national momentum around Individual Coverage Health Reimbursement Arrangements (ICHRAs), with advancing legislation that could codify the model into federal law.
